Drupal.behaviors.print = function(context) {window.print();window.close();}>
Thermo Posts 13 Percent Jump in Q3 Revenues but Lowers Guidance Due to Academic, Government Weakness
October 28, 2011
Thermo Posts 13 Percent Jump in Q3 Revenues but Lowers Guidance Due to Academic, Government Weakness
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Thermo Fisher Reports 15 Percent Rise in Q4 Revenues; Q Exactive Gains Foothold in Q-TOF Market
February 3, 2012 / ProteoMonitor
At JP Morgan Mass Spec Vendors Highlight Clinical Efforts, Performance of High-Profile Releases
January 11, 2013 / ProteoMonitor
Pittcon 2012 Light on LC-MS Product Releases, But Offers Insights into Vendors' Clinical Plans
March 16, 2012 / ProteoMonitor
At JP Morgan, Vendors Tout Strong Mass Spec Releases as Antidotes to Academic/Government Gloom
January 13, 2012 / ProteoMonitor
Mass Spec Vendors Offer Takes on Top-Down Proteomics, UHPLC at UBS Conference
September 23, 2011 / ProteoMonitor